Assessement of Effectiveness of Seawater Nasal Sprays on Sinonasal Symptoms

Recruiting N/A Interventional Study
URTI Bronchiolitis COVID - 19 Allergic Rhinitis Chronic Rhinosinusitis (CRS) Post-surgery
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
15 Days and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
1,065 (estimated)
Sponsor
Laboratoire de la Mer · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The purpose of this post-market clinical investigation is to assess in a real-life setting, the effectiveness, usage, tolerance, safety and satisfaction of 4 isotonic and hypertonic seawater-based CE-marked nasal sprays. The main questions it aims to answer are: * Efficacy, * Safety, * Usage, * Satisfaction, in real-life usage among infants, children, adults and pregnant or breastfeeding women s…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria: * Subject's age and medical condition in compliance with the intended use and population * Subjects who, from the investigator's judgement, should benefit from nasal wash in accordance with routine medical practice * Subjects with at least two nasal symptoms of intensity ≥ 3 (6 …
Contacts

Gaëlle NAELTEN, PharmD / PhD

+330633901291

gaelle.naelten@perrigo.com

CONTACT